Join
Live feed
·
PRReleasevia Quantisnow
Intersect ENT Inc. logo

First Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe

ByQuantisnow·Wall Street's wire, on your screen.
XENT· Intersect ENT Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XENT (Intersect ENT Inc.) and more on Quantisnow.